Literature DB >> 29944475

Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?

Justin M Barber1, Shoshana H Bardach1,2, Gregory A Jicha1,3.   

Abstract

BACKGROUND: Slow participant recruitment impedes Alzheimer disease research progress. Although research suggests that direct involvement with potential participants supports enrollment, strategies for how best to engage potential participants are still unclear.
PURPOSE: This study explores whether community health fair (HF) attendees who engage in a brief cognitive screen (BCS) are more likely to enroll in research than attendees who do not complete a BCS.
SUBJECTS: A total of 483 HF attendees.
METHODS: Attendees were tracked for a 1-year period to ascertain research involvement.
RESULTS: In total, 364 attendees expressed interest in research and 126 completed a BCS. Over the follow-up period, 21 individuals prescreened as eligible and 19 enrolled in an investigational study. Among all HF attendees, BCS completers had a 2.5-fold increase in subsequently prescreening as eligible as compared with non-BCS completers. However, when limited only to participants who stated an interest in research, this difference was no longer significant.
CONCLUSIONS: Completing a BCS at a community event may be an indicator of future research engagement, but for those already interested in participation, the BCS may be a poor indicator of future involvement. The BCS may also reduce anxiety and stigma around memory evaluation, which may translate into research engagement in the future.

Entities:  

Mesh:

Year:  2018        PMID: 29944475      PMCID: PMC6249071          DOI: 10.1097/WAD.0000000000000263

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  12 in total

1.  Perception of overlapping and embedded figures by children of different ages.

Authors:  L GHENT
Journal:  Am J Psychol       Date:  1956-12

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  Screening for dementia with the memory impairment screen.

Authors:  H Buschke; G Kuslansky; M Katz; W F Stewart; M J Sliwinski; H M Eckholdt; R B Lipton
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

4.  Recruitment and enrollment of caregivers for a lifestyle physical activity clinical trial.

Authors:  Caryn D Etkin; Carol J Farran; Lisa L Barnes; Raj C Shah
Journal:  Res Nurs Health       Date:  2011-11-14       Impact factor: 2.228

5.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566

6.  Improving physician awareness of Alzheimer disease and enhancing recruitment: the Clinician Partners Program.

Authors:  James E Galvin; Thomas M Meuser; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Jan-Mar       Impact factor: 2.703

Review 7.  Facilitating Alzheimer disease research recruitment.

Authors:  Joshua D Grill; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

8.  Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials.

Authors:  Sarah A Carr; Roberta Davis; Diane Spencer; Marie Smart; Joanna Hudson; Stephanie Freeman; Greg E Cooper; Fred A Schmitt; William R Markesbery; Deborah Danner; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

Review 9.  Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities.

Authors:  Peter Bower; Valerie Brueton; Carrol Gamble; Shaun Treweek; Catrin Tudur Smith; Bridget Young; Paula Williamson
Journal:  Trials       Date:  2014-10-16       Impact factor: 2.279

10.  Falls Assessment Clinical Trial (FACT): design, interventions, recruitment strategies and participant characteristics.

Authors:  C Raina Elley; M Clare Robertson; Ngaire M Kerse; Sue Garrett; Eileen McKinlay; Beverley Lawton; Helen Moriarty; A John Campbell
Journal:  BMC Public Health       Date:  2007-07-29       Impact factor: 3.295

View more
  4 in total

1.  Recruitment of Older Kidney Transplant Recipients to a Longitudinal Study.

Authors:  Tara O'Brien; Cynthia L Russell; Noor AlKahlout; Anna Rosenthal; Tess Meyer; Alai Tan; Reem Daloul; Donna Hathaway
Journal:  Nurs Res       Date:  2020 May/Jun       Impact factor: 2.381

2.  Real-world Site Experiences With GeneMatch: The Role of a Recruitment-related Registry in the Context of Local Site Effort to Support Alzheimer Disease Prevention Research.

Authors:  Shoshana H Bardach; Jessica B Langbaum; Carey S Kebodeaux; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Apr-Jun 01       Impact factor: 2.703

3.  The Effectiveness of Community-based Outreach Events for the Promotion of African American Research Participation.

Authors:  Shoshana H Bardach; Justin M Barber; Frederick A Schmitt; Linda J Van Eldik; Morgan B Boggess; Markeda Yarbrough; Keisha C Jones; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Oct-Dec       Impact factor: 2.357

4.  Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.

Authors:  Lisa Vermunt; Graciela Muniz-Terrera; Lea Ter Meulen; Colin Veal; Kaj Blennow; Archie Campbell; Isabelle Carrié; Julien Delrieu; Karine Fauria; Gema Huesa Rodríguez; Silvia Ingala; Natalie Jenkins; José Luis Molinuevo; Pierre-Jean Ousset; David Porteous; Niels D Prins; Alina Solomon; Brian D Tom; Henrik Zetterberg; Marissa Zwan; Craig W Ritchie; Philip Scheltens; Gerald Luscan; Anthony J Brookes; Pieter Jelle Visser
Journal:  Alzheimers Res Ther       Date:  2020-01-06       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.